Powering a Ventricular Assist Device over Meter Distances Wirelessly: The Free-Range Resonant Electrical Energy Delivery (FREE-D) System

in CRT. We sought to determine if the HN would attenuate HF progression in patients with stable symptomatic chronic systolic HF implanted with CRT. Methods: Prospective Evaluation of Elastic Restraint to LESSen the effects of Heart Failure (PEERLESS-HF) is a randomized trial comparing the HN plus optimal medical and device therapy versus optimal medical and device therapy alone. Here we report on the long-term outcomes of a subset of 104 patients with CRT (min. duration 3m, mean 1.5 y; LVEF5 23 6 5.5%) out of the total cohort of 210 Stage C HF patients. An independent CEC comprised of HF cardiologists and cardiac surgeons adjudicated causes of deaths and of hospitalizations. Results: The demographics are (T/C): Age:56/56,NYHA III: 36/50%, NI:70/67%, HF duration 8.9/6.9y. None of theobserved differences were statistically significant. The Hazard Ratio and significance levels for important outcomes are presented in the table below.